FDA rejects Lilly’s alzheimer’s drug candidate, seeks more data
January 20, 2023 at 15:43 PM EST
Lilly said it would work with the FDA to evaluate the fastest pathway to get its Alzheimer’s drug to market after what it believes was a successful trial.
